A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions: The SELUTION SFA Japan Trial
The SELUTION SFA JAPAN trial demonstrated that one-year primary patency rate after treatment with the novel SELUTION sirolimus-coated balloon (SCB) was approximately 88% in Japanese patients with femoropopliteal (FP) lesions, Dr. Osamu Iida and colleagues, Osaka Police Hospital, Japan, reported in the 8 July issue of JACC: Cardiovascular Interventions.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.